Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.26p
   
  • Change Today:
    -0.010p
  • 52 Week High: 0.39
  • 52 Week Low: 0.12
  • Currency: UK Pounds
  • Shares Issued: 6,806m
  • Volume: 12,002,718
  • Market Cap: £17.36m

Regulatory News

SVN-015 accepted into US NIDA funded programme 03-Dec-2025 07:00 RNS
Total Voting Rights 31-Oct-2025 15:59 RNS
Corporate Structure Update and Issue of Options 31-Oct-2025 07:00 RNS
Appoints global biopharma leader Paul Carter 27-Oct-2025 07:00 RNS
Raises £1.25 Million to Accelerate Programmes 16-Oct-2025 07:00 RNS
Half-year Report 30-Sep-2025 07:00 RNS
Solvonis secures exclusive CNS collaboration 28-Aug-2025 07:00 RNS
SVN-SDN-14 PTSD - Positive pre-clinical results 12-Aug-2025 07:00 RNS
Total Voting Rights 31-Jul-2025 16:30 RNS
Translational Bridging Studies 22-Jul-2025 07:00 RNS
Exercise of warrants 18-Jul-2025 11:03 RNS
£1m subscription to accelerate AI drug disc... 11-Jul-2025 07:00 RNS
Holding(s) in Company 08-Jul-2025 07:00 RNS
AGM Statement 27-Jun-2025 14:38 RNS
Holding(s) in Company 27-Jun-2025 08:54 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.26p
Change Today -0.010p
% Change -3.77 %
52 Week High 0.39
52 Week Low 0.12
Volume 12,002,718
Shares Issued 6,806m
Market Cap £17.36m

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Price Trend
35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average
40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 10-Dec-2025

Time Volume / Share Price
15:53 34,430 @ 0.26p
15:00 674,230 @ 0.26p
14:21 384,615 @ 0.26p
14:19 55,001 @ 0.25p
14:14 75,253 @ 0.25p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell

Top of Page